Flagship Ventures Fund IV General Partner’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$2.46M Buy
2015
Q4
$4.41M Buy